ADVERTISEMENT

Purdue University Chao Center Doubles Price of TB Drug

I'm confused by your title.

Reading the article it seems that the group, Rodelis, purchased the meds and raised the price. Purdue's nonprofit Chao Center will make it, not distribute, price, or sell it.

From the article:

Officials had no idea that Rodelis planned to charge so much for the drug until reading news reports last week, according to Dan Hasler, the president of the Purdue Research Foundation, which oversees the Chao Center.


"We discovered literally on Thursday the strategy that had been undertaken," Hasler told The Times. "We said this was not what we had intended."

Are you really blaming Purdue?
 
Hey, why concern yourself with facts when there's a noncomparable situation to spew wingnut faux outrage over!
 
"Rodelis Therapeutics and the Chao Center mutually agreed last week that it is in the best interests of the patients to return the rights of Cycloserine to the Chao Center,"
 
"Rodelis Therapeutics and the Chao Center mutually agreed last week that it is in the best interests of the patients to return the rights of Cycloserine to the Chao Center,"

So you ignored my post. Yes, it appears they agreed to make the drug, having no idea that Rodelis was going to jack the cost.
 
So you ignored my post. Yes, it appears they agreed to make the drug, having no idea that Rodelis was going to jack the cost.

The price was $500+ before the Rodelis deal. Chao couldn't afford to make it at that price, so they cut a deal giving the rights to Rodelis.

Chao has since taken the rights back and the price has doubled from the $500+ level:

"The specialty tuberculosis drug will again be produced by the Chao Center, a nonprofit organization associated with Purdue University, according to the reports. The price increase — nearly double the price before Rodelis acquired the rights to cycloserine — will help reduce the amount of money the Chao Center loses in producing the drug."
 
You mean as opposed to raising it 4000% to $10,800. It has now been lowered to the level you are now discussing.
 
So Private Pharm company buys the rights, raises it exponentially, Purdue gets upset, gets the drug back in a deal with the company, and lowers it to double the price.

....and your title calls out Purdue.

Brilliant.
 
ADVERTISEMENT

Latest posts

ADVERTISEMENT